Your browser doesn't support javascript.
loading
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.
Fechina, Larisa; Popov, Alexander; Tsaur, Grigory; Henze, Guenter; Shorikov, Egor; Makarova, Olga; Khlebnikova, Olga; Zhukova, Yulia; Arakaev, Oleg; Streneva, Olga; Verzhbitskaya, Tatiana; Riger, Tatiana; Solodovnikov, Alexander; Lapotentova, Elena; Aleinikova, Olga; Myakova, Natalia; Boichenko, Elmira; Kondratchik, Konstantin; Nikonova, Olga; Shapochnik, Alexander; Goroshkova, Marina; Ponomareva, Natalia; Novichkova, Galina; Karachunskiy, Alexander; Roumiantsev, Alexander.
Affiliation
  • Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Popov A; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Tsaur G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Henze G; Regional Children's Hospital, Ekaterinburg, Russian Federation. tsaurga@mis66.ru.
  • Shorikov E; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation. tsaurga@mis66.ru.
  • Makarova O; Ural State Medical University, Ekaterinburg, Russian Federation. tsaurga@mis66.ru.
  • Khlebnikova O; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Zhukova Y; PET-Technology Center of Nuclear Medicine, Ekaterinburg, Russian Federation.
  • Arakaev O; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Riger T; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Solodovnikov A; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Lapotentova E; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Aleinikova O; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Myakova N; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Boichenko E; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Kondratchik K; Regional Children's Hospital, Ekaterinburg, Russian Federation.
  • Nikonova O; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
  • Shapochnik A; Ural State Medical University, Ekaterinburg, Russian Federation.
  • Goroshkova M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Ponomareva N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Novichkova G; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.
  • Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
  • Roumiantsev A; City Children's Hospital №1, Saint-Petersburg, Russian Federation.
Leukemia ; 37(11): 2276-2281, 2023 11.
Article in En | MEDLINE | ID: mdl-37741948
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans / Infant Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma Limits: Humans / Infant Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2023 Document type: Article